Northwire Canada EditionFriday, October 16, 2026
Sign inSubscribe
Northwire
⌕
GOLD 4170.10 +1.5% SILVER 57.16 +2.3% COPPER 6.56 −1.5% OIL 97.97 +3.0% PALLADIUM 1136.00 +3.6% LUN 32.91 +0.6% DLP 0.290 −3.3% VCV 0.065 −13.3% GG 2.89 +1.4% NBLC 0.015 +0.0% SF 0.300 −4.8% ATY 0.215 +2.4% GHL 0.060 −7.7% STND 0.060 −7.7% B 0.550 −3.5% HBM 34.33 −0.5% NTR 98.77 −0.7% SGZ 0.035 +0.0% MKA 0.670 +0.0% LXM 0.175 −18.6% CLCH 1.08 −1.8% GOLD 4170.10 +1.5% SILVER 57.16 +2.3% COPPER 6.56 −1.5% OIL 97.97 +3.0% PALLADIUM 1136.00 +3.6% LUN 32.91 +0.6% DLP 0.290 −3.3% VCV 0.065 −13.3% GG 2.89 +1.4% NBLC 0.015 +0.0% SF 0.300 −4.8% ATY 0.215 +2.4% GHL 0.060 −7.7% STND 0.060 −7.7% B 0.550 −3.5% HBM 34.33 −0.5% NTR 98.77 −0.7% SGZ 0.035 +0.0% MKA 0.670 +0.0% LXM 0.175 −18.6% CLCH 1.08 −1.8%

Healthcare

Page 38
  1. Apr 02, 2026 · 07:00 · WELL

    WELL Health Partners with AliveCor to Bring AI-Powered Cardiac Monitoring and Cardiologist Oversight to Canadians

    WELL Health Partners with AliveCor to Bring AI-Powered Cardiac Monitoring and Cardiologist Oversight to Canadians

    01
  2. Apr 02, 2026 · 05:45 · ARCH

    Arch Biopartners Closes Non-Brokered Private Placement

    Arch Biopartners Closes Non-Brokered Private Placement

    02
  3. Apr 01, 2026 · 22:50 · VPT

    Ventripoint Diagnostics Announces Collaboration with the Health Division of the Montecristo Group

    Ventripoint Diagnostics Announces Collaboration with the Health Division of the Montecristo Group

    03
  4. Apr 01, 2026 · 22:00 · MIR

    MedMira Reports Second Quarter Results FY2025

    MedMira Reports Second Quarter Results FY2025

    04
  5. Apr 01, 2026 · 21:05 · EXE

    Extendicare closes $570M CHI Home Health acquisition

    Extendicare closes $570M CHI Home Health acquisition

    05
  6. Apr 01, 2026 · 15:45 · MBIO

    MindBio Announces Closing of Private Placement

    MindBio Announces Closing of Private Placement

    06
  7. Apr 01, 2026 · 09:18 · EXE

    Extendicare Acquires CBI Home Health

    Extendicare Acquires CBI Home Health

    07
  8. Apr 01, 2026 · 09:00 · OTC

    Ocumetics to Showcase First-In-human Results with Industry Leaders & Potential Strategic Partners at ASCRS Annual Meeting

    Ocumetics to Showcase First-In-human Results with Industry Leaders & Potential Strategic Partners at ASCRS Annual Meeting

    08
  9. Apr 01, 2026 · 08:55 · ONCO

    OneMedNet, Onco-Innovations and Inka Health Announces Collaboration Aimed to Accelerate Potential for Oncology Drug Development Using Real-World Data and AI

    OneMedNet, Onco-Innovations and Inka Health Announces Collaboration Aimed to Accelerate Potential for Oncology Drug Development Using Real-World Data and AI

    09
  10. Apr 01, 2026 · 08:02 · QNTM

    Quantum BioPharma Submits Investigational New Drug (IND) Application to United States Food and Drug Administration (FDA) for Lucid-MS Phase Two Clinical Trial in Multiple Sclerosis

    Quantum BioPharma Submits Investigational New Drug (IND) Application to United States Food and Drug Administration (FDA) for Lucid-MS Phase Two Clinical Trial in Multiple Sclerosis

    10
  11. Apr 01, 2026 · 08:00 · 4568

    Nuvation Bio Announces Acquisition of Japan Rights to Safusidenib from Daiichi Sankyo

    Nuvation Bio Announces Acquisition of Japan Rights to Safusidenib from Daiichi Sankyo

    11
  12. Apr 01, 2026 · 07:30 · NPTH

    NEUPATH HEALTH ANNOUNCES PROPOSED SHARES FOR DEBT SETTLEMENT

    NEUPATH HEALTH ANNOUNCES PROPOSED SHARES FOR DEBT SETTLEMENT

    12
  13. Apr 01, 2026 · 07:28 · CRDL

    Cardiol Therapeutics Announces Year-End 2025 Update on Operations

    Cardiol Therapeutics Announces Year-End 2025 Update on Operations

    13
  14. Mar 31, 2026 · 20:55 · BCT

    Briacell completes licence acquisition by BriaPro

    Briacell completes licence acquisition by BriaPro

    14
← Newer Older →